NCT07137624 Motor Imagery and Action Observation for Gait Function in MS
| NCT ID | NCT07137624 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Multiple Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-01-03 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-01-03 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will investigate whether mentally simulating walking movements while watching others walk can improve walking performance in individuals with Multiple Sclerosis (MS). Participants will be divided into two groups: one group will watch walking videos and imagine themselves walking, while the other group will watch nature scenes. The study will measure muscle activity and walking patterns to assess the effects. The results may help support the use of mental practice techniques to improve mobility in people with MS.
Eligibility Criteria
Inclusion Criteria: * A confirmed diagnosis of multiple sclerosis (MS) by a neurologist * No history of relapse within the past 3 months and not currently experiencing a relapse * A score of 24 or higher on the standardized Mini Mental State Examination Exclusion Criteria: * Presence of serious health conditions affecting the muscles, heart, lungs, or metabolism that could interfere with participation * History of other neurological disorders, head injury, or chronic psychiatric conditions * Chronic pain lasting longer than six months * Significant muscle stiffness in the legs that may affect EMG recordings * Hearing difficulties * Vision problems as determined by the Snellen visual acuity test
Contact & Investigator
Yeliz Salcı, Assoc. Prof.
STUDY CHAIR
Hacettepe University
Frequently Asked Questions
Who can join the NCT07137624 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07137624 currently recruiting?
Yes, NCT07137624 is actively recruiting participants. Contact the research team at merveunal.144@gmail.com for enrollment information.
Where is the NCT07137624 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07137624 clinical trial?
NCT07137624 is sponsored by Hacettepe University. The principal investigator is Yeliz Salcı, Assoc. Prof. at Hacettepe University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.